KYNA Ameliorates Glutamate Toxicity of HAND by Enhancing Glutamate Uptake in A2 Astrocytes
International Journal of Molecular Sciences · 12.04.2024 · 25 (8) · 4286
DOI: 10.3390/ijms25084286 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.04.2024. Verfasst von Jie Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), …. Hauptthemen laut MEDLINE: Astrocytes, Glutamic Acid, Kynurenine. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Reactive astrocytes are key players in HIV-associated neurocognitive disorders (HAND), and different types of reactive astrocytes play opposing roles in the neuropathologic progression of HAND. A recent study by our group found that gp120 mediates A1 astrocytes (neurotoxicity), which secrete proinflammatory factors and promote HAND disease progression. Here, by comparing the expression of A2 astrocyte (neuroprotective) markers in the brains of gp120 tgm mice and gp120+/α7nAChR−/− mice, we found that inhibition of alpha 7 nicotinic acetylcholine receptor (α7nAChR) promotes A2 astrocyte generation. Notably, kynurenine acid (KYNA) is an antagonist of α7nAChR, and is able to promote the formation of A2 astrocytes, the secretion of neurotrophic factors, and the enhancement of glutamate uptake through blocking the activation of α7nAChR/NF-κB signaling. In addition, learning, memory and mood disorders were significantly improved in gp120 tgm mice by intraperitoneal injection of kynurenine (KYN) and probenecid (PROB). Meanwhile, the number of A2 astrocytes in the mouse brain was significantly increased and glutamate toxicity was reduced. Taken together, KYNA was able to promote A2 astrocyte production and neurotrophic factor secretion, reduce glutamate toxicity, and ameliorate gp120-induced neuropathological deficits. These findings contribute to our understanding of the role that reactive astrocytes play in the development of HAND pathology and provide new evidence for the treatment of HAND via the tryptophan pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou 510515, China.
ORCID-Profile: Jinhu Zou, Xuefeng Gao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, J., Zou, J., Huang, P., Gao, X., Lun, J., Li, Y., Gong, Z., & Cao, H. (2024). KYNA Ameliorates Glutamate Toxicity of HAND by Enhancing Glutamate Uptake in A2 Astrocytes. International Journal of Molecular Sciences, 25(8), 4286. https://doi.org/10.3390/ijms25084286
Vancouver
Chen J, Zou J, Huang P, Gao X, Lun J, Li Y, et al. KYNA Ameliorates Glutamate Toxicity of HAND by Enhancing Glutamate Uptake in A2 Astrocytes. International Journal of Molecular Sciences. 2024;25(8):4286. doi:10.3390/ijms25084286
BibTeX
@article{Chen2024,
author = {Chen, Jie and Zou, Jinhu and Huang, Pengwei and Gao, Xuefeng and Lun, Jingxian and Li, Yubin and Gong, Zelong and Cao, Hong},
title = {KYNA Ameliorates Glutamate Toxicity of HAND by Enhancing Glutamate Uptake in A2 Astrocytes},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {8},
pages = {4286},
doi = {10.3390/ijms25084286}
}
EUVIMED